Global Metabolism Drugs Market to Grow at 5.7% CAGR, Reaching USD 22.91 Billion by 2032
According to a new report from Intel Market Research, the global Metabolism Drugs market was valued at USD 15,640 million in 2024 and is projected to reach USD 22,910 million by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032). This growth is propelled by increasing prevalence of metabolic disorders, advancements in targeted therapies, and growing healthcare expenditure...
0 Comments 0 Shares 0 Reviews
Sponsored
Sponsored